Examine finds Novavax COVID jab protected, efficient for adolescents
A randomized scientific trial has discovered that the COVID-19 vaccine produced by Novavax Inc. is “safe, immunogenic, and efficacious in preventing” the coronavirus in adolescents.
Eighteen researchers from a federally funded COVID vaccine enlargement research group printed the trial outcomes Wednesday in...










